aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
2.990
-0.050 (-1.64%)
At close: Nov 20, 2024, 4:00 PM
2.931
-0.059 (-1.97%)
After-hours: Nov 20, 2024, 4:50 PM EST
aTyr Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 227 | 83 | 64 | 208 | 40 | 16 | |
| Market Cap Growth | 48.01% | 29.97% | -69.40% | 425.30% | 143.62% | 9.00% | |
| Enterprise Value | 174 | -5 | -5 | 93 | 9 | -8 | |
| Last Close Price | 2.99 | 1.41 | 2.19 | 7.47 | 3.88 | 4.17 | |
| Debt / Equity Ratio | 0.21 | 0.17 | 0.16 | 0.01 | 0.07 | 0.56 | |
| Asset Turnover | 0.00 | 0.00 | 0.10 | - | 0.28 | 0.01 | |
| Quick Ratio | 4.80 | 6.13 | 5.62 | 18.02 | 5.41 | 2.42 | |
| Current Ratio | 5.41 | 6.27 | 5.83 | 18.89 | 6.06 | 2.47 | |
| Return on Equity (ROE) | -78.14% | -62.31% | -50.27% | -48.04% | -61.82% | -86.92% | |
| Return on Assets (ROA) | -39.26% | -31.72% | -27.45% | -27.56% | -26.55% | -32.30% | |
| Return on Capital (ROIC) | -44.28% | -36.44% | -30.00% | -29.48% | -29.92% | -34.84% | |
| Buyback Yield / Dilution | -48.50% | -88.63% | -48.94% | -108.30% | -172.98% | -56.66% | |
| Total Shareholder Return | -48.50% | -88.63% | -48.94% | -108.30% | -172.98% | -56.66% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.